Renal thrombotic microangiopathy in a genetic model of hypertension in mice

Experimental Biology and Medicine

Volumn 231, Issue 2, 2006, Pages 196-203

  Sethi, Sanjeev ^a   Iida, Shinichiro ^b   Sigmund, Curt D ^b   Heistad, Donald D ^b  

^a MAYO CLINIC   (United States)

^b UNIVERSITY OF IOWA   (United States)

Author keywords

Hypertension; Renal thrombotic microangiopathy; Renin angiotensin; Transgenic mice

Indexed keywords

ANGIOTENSINAMIDE; N(G) NITROARGININE METHYL ESTER; NITRIC OXIDE SYNTHASE INHIBITOR;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTERIAL PRESSURE; ARTICLE; BLOOD VESSEL WALL; CAPILLARY WALL; CONTROLLED STUDY; DIETARY INTAKE; DISEASE SEVERITY; FEEDING; FEMALE; GENETIC MODEL; GLOMERULUS CAPILLARY; HYPERTENSION; KIDNEY FUNCTION; MALIGNANT HYPERTENSION; MORPHOLOGY; MOUSE; NONHUMAN; SCLEROSIS; THROMBOTIC THROMBOCYTOPENIC PURPURA; VASCULAR LESION;

ALLIUM CEPA; ANIMALIA; MURINAE; MUS MUSCULUS;

EID: 32244442964     PISSN: 15353702     EISSN: 15353699     Source Type: Journal    
DOI: 10.1177/153537020623100210     Document Type: Article

References (25)

1. Kannel WB. Blood pressure as a cardiovascular risk factor: prevention and treatment. JAMA 275:1571-1576, 1996.
2. Brenner BC. Brenner and Rector's The Kidney (6th ed.). Philadelphia: W.B. Saunders Company, pp1967-2006, 2000.
3. Jennette JC, Olson JL, Schwartz MM, Silva FG. Heptinstall's Pathology of the Kidney (5th ed.). Philadelphia: Lippincott-Raven, pp943-1001, 1998.
4. Thompson MW, Merrill DC, Yang G, Robillard JE, Sigmund CD. Transgenic animals in the study of blood pressure regulation and hypertension. Am J Physiol Endocrinol Metab 269:E793-803, 1995.
5. Lavoie JL, Lake-Bruse KD, Sigmund CD. Increased blood pressure in transgenic mice expressing both human renin and angiotensinogen in the renal proximal tubule.Am J Physiol Renal Physiol 286:F965-971, 2004.
6. Merrill DC, Thompson MW, Carney CL, Granwehr BP, Schlager G, Robillard JE, Sigmund CD. Chronic hypertension and altered baroreflex responses in transgenic mice containing the human renin and human angiotensinogen genes. J Clin Invest 97:1047-1055, 1996.
7. Cvetkovic B, Sigmund CD. Understanding hypertension through genetic manipulation in mice. Kidney Int 57:863-874, 2000.
8. Davisson RL, Ding Y, Stec DE, Catterall JF, Sigmund CD. Novel mechanism of hypertension revealed by cell-specific targeting of human angiotensinogen in transgenic mice. Physiol Genomics 1:3-9, 1999.
9. Baumbach GL, Sigmund CD, Faraci FM. Cerebral arteriolar structure in mice overexpressing human renin and angiotensinogen. Hypertension 41:50-55, 2003.
10. Iida S, Baumbach GL, Lavoie JL, Faraci FM, Sigmund CD, Heistad DD. Spontaneous stroke in a genetic model of hypertension in mice. Stroke 36:1253-1258, 2005.
11. Keen HL, Sigmund CD. Paradoxical regulation of short promoter human renin transgene by angiotensin II. Hypertension 37:403-407, 2001.
12. Shimokama THS, Horiguchi H, Sugiyama F, Murakami K, Watanabe T. The Tsukuba hypertensive mouse (transgenic mouse carrying human genes for both renin and angiotensinogen) as a model of human malignant hypertension: development of lesions and morphometric analysis. Virchows Arch 432:169-175, 1998.
13. Nishijo N, Takamine S, Sugiyama F, Kimoto K, Taniguchi K, Horiguchi H, Ogata T, Murakami K, Fukamizu A, Yagami K. Vascular remodeling in hypertensive transgenic mice. Exp Anim 48:203-208, 1999.
14. Kai T, Sugimura K, Shimada S, Kurooka A, Takenaka T, Ishikawa K. Enhanced angiotensin II stimulates renal disorders in transgenic Tsukuba hypertensive mice. Blood Press 7:247-250, 1998.
15. Kai T, Kino H, Sugimura K, Shimada S, Kurooka A, Akamatsu K, Takenaka T, Fukamizu A, Murakami K, Ishikawa K, Katori R. Significant role of the increase in renin-angiotensin system in cardiac hypertrophy and renal glomerular sclerosis in double transgenic tsukuba hypertensive mice carrying both human renin and angiotensinogen genes. Clin Exp Hypertens 20:439-449, 1998.
16. Bohlender J, Fukamizu A, Lippoldt A, Nomura T, Dietz R, Menard J, Murakami K, Luft FC, Ganten D. High human renin hypertension in transgenic rats. Hypertension 29:428-434, 1997.
17. Bohlender J, Ganten D, Luft FC. Rats transgenic for human renin and human angiotensinogen as a model for gestational hypertension. J Am Soc Nephrol 11:2056-2061, 2000.
18. Ogata J, Fujishima M, Tamaki K, Nakatomi Y, Ishitsuka T, Omae T. Stroke-prone spontaneously hypertensive rats as an experimental model of malignant hypertension. A pathological study. Virchows Arch A Pathol Anat Histol 394:185-194, 1982.
19. Maric C, Sandberg K, Hinojosa-Laborde C. Glomerulosclerosis and tubulointerstitial fibrosis are attenuated with 17{beta}-estradiol in the aging dahl salt sensitive rat. J Am Soc Nephrol 15:1546-1556, 2004.
20. Ofstad J, Iversen BM. Glomerular and tubular damage in normotensive and hypertensive rats. Am J Physiol Renal Physiol 288:F665-672, 2005.
21. Takizawa T, Takasaki I, Shionoiri H, Ishii M. Progression of glomerulosclerosis, renal hypertrophy, and an increased expression of fibronectin in the renal cortex associated with aging and salt-induced hypertension in dahl salt-sensitive rats. Life Sciences 61:1553-1558, 1997.
22. Komatsu K, Frohlich ED, Ono H, Ono Y, Numabe A, Willis GW. Glomerular dynamics and morphology of aged spontaneously hypertensive rats: effects of angiotensin-converting enzyme inhibition. Hypertension 25:207-213, 1995.
23. Ono H, Ono Y, Frohlich ED. Nitric oxide synthase inhibition in spontaneously hypertensive rats: systemic, renal, and glomerular hemodynamics. Hypertension 26:249-255, 1995.
24. Rocha R, Chander PN, Zuckerman A, Stier CT Jr. Role of aldosterone in renal vascular injury in stroke-prone hypertensive rats. Hypertension 33:232-237, 1999.
25. Chander PN, Rocha R, Ranaudo J, Singh G, Zuckerman A, Stier CT Jr. Aldosterone plays a pivotal role in the pathogenesis of thrombotic microangiopathy in SHRSP. J Am Soc Nephrol 14:1990-1997, 2003.